TG2 overexpression in metastatic breast cancer promotes apoptosis-resistance phenotype, cell migration and invasion by initiating integrin-mediated cell attachment and cell survival signalling pathways [14], [35]–[37]. The gene discussed is TGM2; the disease is breast cancer.